Fangda has advised XtalPi Holdings Limited. XtalPi Holdings Limited has completed a placement of approximately 286 million new shares, raising net proceeds of around HKD 2.65...
You must be a Standard 1 Year member to access this content.
Fangda Partners has advised WuXi XDC Cayman Inc. WuXi XDC Cayman Inc. (HK stock code: 2268) has completed a primary placement of 22,227,000 new shares at...
You must be a Standard 1 Year member to access this content.
Fangda advised QuantumPharm on the offering. QuantumPharm Inc. was successfully listed on the Main Board of the Stock Exchange of Hong Kong Limited and launched a globally...
You must be a Standard 1 Year member to access this content.
Fangda represented HLC on the deal. Viva Biotech Holdings Group completed the equity financing at both Viva Holdings and its subsidiary Viva Biotech (Shanghai) Ltd., bringing in...
You must be a Standard 1 Year member to access this content.
Fangda advised WuXi XDC Cayman Inc. on the deal. WuXi XDC Cayman Inc. successfully spun-off from WuXi Biologics (Cayman) Inc. for a separate listing on the Main...
You must be a Standard 1 Year member to access this content.
Morgan Lewis advised True Green Capital Management on the deal. True Green Capital Management (TGC), a renewable energy infrastructure private equity fund manager, announced the final...
You must be a Standard 1 Year member to access this content.
